Home Capital Broker's Calls

Accretive acquisitions may boost Parkway Life REIT’s share price: CGS-CIMB

Felicia Tan
Felicia Tan7/28/2021 5:26 PM GMT+08  • 2 min read
Accretive acquisitions may boost Parkway Life REIT’s share price: CGS-CIMB
The analysts have kept "add" on the REIT with the same target price of $5.05.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

As Parkway Life REIT registered another quarter of growth in the 2QFY2021 ended June, CGS-CIMB Research analysts Lock Mun Yee and Eing Kar Mei have kept “add” on the REIT with an unchanged target price of $5.05.

See: Parkway Life REIT posts 0.7% higher 2Q21 DPU of 3.38 cents; 4% higher 1H21 DPU of 6.95 cents

The REIT’s 1HFY2021 distribution per unit (DPU) of 6.95 cents stood within their expectations at 49.2% of their FY2021 forecast, they write in a July 27 report.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.